Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 PK/PD Study of RDEA594 in Gout Patients With Moderate Renal Insufficiency
2009-014762-26Phase 2Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lesinurad in gout and hyperuricemia (2 arms), sponsored by Ardea Biosciences, Inc. Primary endpoint: Safety of RDEA594. Started Sep 2009; status: completed.
02
Drugs
lesinurad
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on 2009-014762-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014762-26.